During the past decade, Dept Internal Medicine Gastrointestinal Oncology Unit conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dept Internal Medicine Gastrointestinal Oncology Unit" are "Gastric Adenocarcinoma" (1 trials), "Gastroesophageal Adenocarcinoma" (1 trials) and "Locally Advanced or Metastatic Adenoca of the Biliary Tract" (1 trials). Many other conditions were trialed in "Dept Internal Medicine Gastrointestinal Oncology Unit" in a lesser frequency.

Most popular intervention types in "Dept Internal Medicine Gastrointestinal Oncology Unit" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "OSI-7904L" (2 trials) and "5-Fluorouracil/Leucovorin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dept Internal Medicine Gastrointestinal Oncology Unit" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Dept Internal Medicine Gastrointestinal Oncology Unit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Dept Internal Medicine Gastrointestinal Oncology Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dept Internal Medicine Gastrointestinal Oncology Unit, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".